All patients (n = 140) | Inactive(I) (n = 47) | Active(A) (n = 93) | P (I-A) | |
---|---|---|---|---|
Mean ± SD | ||||
HADS anxiety | 5.46 ± 3.54 | 6.69 ± 3.64 | 4.87 ± 3.35 | 0.004 |
HADS depression | 3.05 ± 3.19 | 4.87 ± 3.84 | 2.17 ± 2.38 | <0.001 |
PSS | 4.55 ± 2.80 | 5.93 ± 2.83 | 3.87 ± 2.53 | <0.001 |
SOC | 66.90 ± 11.26 | 62.55 ± 69.03 | 69.03 ± 10.51 | 0.002 |
DAS total | 49.35 ± 18.94 | 54.79 ± 22.01 | 46.80 ± 16.86 | 0.022 |
DAS perfection | 28.41 ± 12.61 | 31.98 ± 14.94 | 26.74 ± 11.07 | 0.024 |
DAS dependency | 20.94 ± 8.01 | 22.81 ± 8.35 | 20.07 ± 7.74 | 0.063 |
Number of patients (%) | ||||
HADS anxiety | ||||
normal score: 0–7 | 104 (75%) | 26 (57%) | 78 (84%) | 0.004 |
borderline: 8–11 | 21 (15%) | 12 (27%) | 9 (10%) | |
abnormal: 11–21 | 13 (10%) | 7 (16%) | 6 (6%) | |
HADS depression | ||||
normal score: 0–7 | 124 (90%) | 35 (78%) | 89 (96%) | 0.005 |
borderline: 8–10 | 8 (6%) | 6 (13%) | 2 (2%) | |
abnormal: 11–21 | 6 (4%) | 4 (9%) | 2 (2%) | |
GHQ | ||||
normal score: 0–4 | 124 (90%) | 35 (78%) | 89 (96%) | 0.002 |
abnormal: ≥5 | 14 (10%) | 10 (22%) | 4 (4%) |